2022
Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study
Dhodapkar MM, Shi X, Ramachandran R, Chen EM, Wallach JD, Ross JS. Characterization and corroboration of safety signals identified from the US Food and Drug Administration Adverse Event Reporting System, 2008-19: cross sectional study. The BMJ 2022, 379: e071752. PMID: 36198428, PMCID: PMC9533298, DOI: 10.1136/bmj-2022-071752.Peer-Reviewed Original ResearchConceptsPotential safety signalsSafety signalsSectional studyUS FoodDrug Administration Adverse Event Reporting SystemLiterature searchAdverse Event Reporting SystemSentinel InitiativeDrug Safety CommunicationsEvent Reporting SystemDrug safety signalsAdverse eventsCase seriesCase reportRegulatory actionDrug labelingSignificant associationFDA regulatory actionsComprehensive safety evaluationFAERSFDA
2012
Association between physician quality improvement incentives and ambulatory quality measures.
Bishop TF, Federman AD, Ross JS. Association between physician quality improvement incentives and ambulatory quality measures. The American Journal Of Managed Care 2012, 18: e126-34. PMID: 22554038, PMCID: PMC3537503.Peer-Reviewed Original ResearchConceptsHigh-quality ambulatory carePreventive care visitsWeight reduction counselingAmbulatory careReduction counselingCare visitsNational Ambulatory Medical Care SurveySignificant associationAmbulatory Medical Care SurveyAmbulatory medical careBody mass indexCross-sectional studyPublic reportingAmbulatory quality measuresPhysician compensationOverweight patientsObese patientsPreventive visitsMultivariable analysisMass indexCare SurveyPatient satisfactionQuality improvement incentivesMedical carePatients